- Home
- RMTI vs IOVA Comparison
RMTI vs IOVA Comparison
Compare RMTI & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMTI
- IOVA
- Stock Information
- Founded
- RMTI 1994
- IOVA 2007
- Country
- RMTI United States
- IOVA United States
- Employees
- RMTI N/A
- IOVA N/A
- Industry
- RMTI Biotechnology: Pharmaceutical Preparations
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RMTI Health Care
- IOVA Health Care
- Exchange
- RMTI Nasdaq
- IOVA Nasdaq
- Market Cap
- RMTI 34.9M
- IOVA 1.0B
- IPO Year
- RMTI 1998
- IOVA N/A
- Fundamental
- Price
- RMTI $1.13
- IOVA $1.72
- Analyst Decision
- RMTI Strong Buy
- IOVA Strong Buy
- Analyst Count
- RMTI 2
- IOVA 9
- Target Price
- RMTI $4.00
- IOVA $18.22
- AVG Volume (30 Days)
- RMTI 194.8K
- IOVA 9.3M
- Earning Date
- RMTI 05-12-2025
- IOVA 05-08-2025
- Dividend Yield
- RMTI N/A
- IOVA N/A
- EPS Growth
- RMTI N/A
- IOVA N/A
- EPS
- RMTI N/A
- IOVA N/A
- Revenue
- RMTI $101,489,000.00
- IOVA $164,070,000.00
- Revenue This Year
- RMTI N/A
- IOVA $182.20
- Revenue Next Year
- RMTI $10.42
- IOVA $62.10
- P/E Ratio
- RMTI N/A
- IOVA N/A
- Revenue Growth
- RMTI 21.38
- IOVA 13698.99
- 52 Week Low
- RMTI $0.86
- IOVA $2.70
- 52 Week High
- RMTI $5.15
- IOVA $13.60
- Technical
- Relative Strength Index (RSI)
- RMTI 49.12
- IOVA 24.56
- Support Level
- RMTI $1.08
- IOVA $3.02
- Resistance Level
- RMTI $1.21
- IOVA $3.31
- Average True Range (ATR)
- RMTI 0.07
- IOVA 0.24
- MACD
- RMTI 0.02
- IOVA -0.08
- Stochastic Oscillator
- RMTI 48.33
- IOVA 6.00
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.